Zoom the image with mouse
Online Support Have Questions?Ask An Expert

Effaclar Duo+ Cream Spf30 40Ml

2 sold in last 8 hours
Boots Store
6927165
La Roche-Posay
Seller Profile:
£33.35
Size Guide
£33.35
Terms & conditions
customers are viewing this product

La Roche-Posay Effaclar Duo+ Cream SPF30 40ml

A spot treatment that corrects and moisturises for clearer skin in 4 weeks. Now with broad spectrum protection against UVA, UVB and pollution.
SPECIFICALLY FORMULATED FOR
Specifically formulated for oily and acne-prone skin in both adults and teenagers. A dual action daily gel-moisturiser that minimises the appearance of spots and blackheads, limits shine and reduces inflammation in order to prevent red and brown pigmentation marks that are sometimes left by spots. Provides immediate protection from UVA and UVB rays. Helps shield the skin from the damaging effects of pollution and infrared over time. Keeps skin hydrated for 24 hours. Clearer skin in 4 weeks. Suitable for even sensitive skin.
Anti-blemish treatment that corrects and moisturises oily and acne-prone skin
Noticeably reduces spots, controls shine and reduces the appearance of dark marks
With broad spectrum UV protection
ACTIVE INGREDIENTS
Enriched with LHA to exfoliate the skin, unclog blocked pores and minimise the appearance of scarring. Also contains niacinamide to help reduce redness and size of spots, as well as soothe irritation caused by spots.
Enriched with [ACTIVE SHIELD XL PROTECT] with SPF 30, PPD (UVA protection) and Carnosine, an anti-oxidant, that helps shield from damage caused by pollution.
DERMATOLOGICALLY TESTED
Effaclar has been rigorously dermatologically tested to ensure it is suitable for use on even the most sensitive skin.
9/10 dermatologists would recommend La Roche-Posay Effaclar for oily, spot-prone skin*

MINIMALIST HYPO-ALLERGENIC FORMULA
The minimalist formula contains no parabens, no preservatives no soap, no colourants and no lanolin. It is hypoallergenic and non-comedogenic (won't block pores).
*Survey of 249 dermatologists at the British Association of Dermatologist conference, July 2015. Survey conducted by La Roche-Posay

The cookie settings on this website are set to 'allow all cookies' to give you the very best experience. Please click Accept Cookies to continue to use the site.
Effaclar Duo+ Cream Spf30 40Ml
You have successfully subscribed!
This email has been registered
ico-collapse
0
ic-cross-line-top
Top
ic-expand
ic-cross-line-top